MFSD2A and paraplegia: In addition, we have previously associated delayed paraplegia at 48-h post-ACC with miR-155 targeting transcripts encoding major facilitator superfamily domain containing 2A (Mfsd2a) (Awad et al., 2018), a transporter implicated in the maintenance of the integrity of the blood-brain barrier (Ben-Zvi et al., 2014) that also delivers docosahexaenoic acid (DHA) to the brain (Nguyen et al., 2014).